ESMO Conference Platform

ESMO Breast Cancer 2022

Final Programme PDF Advanced Search

11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00

Berlin Hall

13:10(30m)ESMO Breast Cancer 2022 Award lecture
15:40(30m)Keynote lecture: Optimising adjuvant treatment in HR+/HER2 negative early breast cancer
13:00(10m)Welcome to the ESMO Breast Cancer Congress 2022

Frankfurt Hall

16:15(1h 15m)Mini Oral session 1
13:45(1h 30m)Risk based prevention and screening in breast cancer
11:30(1h)YO “HowTo” Session: How to move genomic profiling to clinical practice by multidisciplinary collaboration?

Hamburg Hall

16:15(1h 30m)Immunotherapy of metastatic breast cancer: Where do we stand?
13:45(1h 30m)Neo-adjuvant and adjuvant triple negative breast cancer (TNBC)
18:00(1h)Roche - The opportunities and challenges of targeting pathways in HER2-positive BC beyond HER2
11:30(1h)Sanofi Genzyme - Tumor Board: How The Experts Approach Personalized Care Plans in ER-Positive Breast Cancer

Munich Hall

18:00(1h 30m)ESMO Colloquium supported by Lilly - Optimising risk prediction, management and compliance for patients with early HR+ HER2- breast cancer: The start of a journey
11:30(1h)Gilead - Triple-Negative Breast Cancer: See Beyond the Negatives
16:15(1h 30m)How to collect and use PRO data in clinical settings
13:45(1h 30m)Proffered Paper session 1

Cologne Hall

11:30(1h)AstraZeneca - Controversies in Breast Cancer
18:00(1h)YO Vesalius talk: The road to a successful career in breast oncology research